Inhibition of growth of primary and metastatic Lewis lung carcinoma cells by the phosphodiesterase inhibitor isobutylmethylxanthine.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D005260:Female; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology; D008297:Male; D051379:Mice; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000473:pathology*; D013806:Theophylline / Q000031:analogs & derivatives*
D013806:Theophylline; D015056:1-Methyl-3-isobutylxanthine